Alvotech And Bioventure Celebrate Egyptian Adalimumab Nod

Partnered AVT02 Biosimilar Rival To Humira Approved As Adalimumab-EVA

 
• By David Wallace
Syringe and vial labelled with Egyptian flag
Alvotech and Bioventure have celebrated an Egyptian biosimilar approval • Source: Shutterstock

More from Biosimilars

More from Products